Skip to main content
HLB Genex, Inc. logo

HLB Genex, Inc. — Investor Relations & Filings

Ticker · 187420 ISIN · KR7187420005 KO Manufacturing
Open in API
Filings indexed 262 across all filing types
Latest filing 2026-01-15 Major Shareholding Noti…
Country KR South Korea
Listing KO 187420

About HLB Genex, Inc.

http://hlbgenex.com/

HLB Genex, Inc. is a biotechnology company that develops and produces customized enzyme and microbiome-based solutions. The company's core activities involve the research, development, and manufacturing of industrial special enzymes and bio-healthcare ingredients. Its key products include enzymes like Lactase for food applications, Catalase for eco-friendly industrial processes, and Proteinase K for molecular diagnostics. In the bio-healthcare segment, it produces Vitamin K2 (Menaquinone 7) for bone and cardiovascular health and Phytosphingosine for cosmeceuticals. The company utilizes proprietary platform technologies, such as Microbial Surface Display and Spore Biologics, to develop its products and advance its pipeline of microbiome therapeutics by identifying effector molecules, also known as postbiotics.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (HLB Co., Ltd.) and its special related parties in the issuer (HLB Genex Co., Ltd.). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2026-01-15 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (DART system) used to disclose significant changes in share ownership (crossing thresholds). This falls under the 'Major Shareholding Notification' category.
2025-12-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities (Financial Supervisory Service/Korea Exchange). This type of filing is a mandatory disclosure for insiders (directors, officers, and major shareholders) regarding changes in their shareholdings or derivative securities (like convertible bonds). In the provided taxonomy, this falls under 'Director's Dealing' (DIRS), which covers insider transactions and ownership changes.
2025-12-19 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including special relationships, contract details (call options, convertible bonds), and the purpose of holding (influence on management). This falls under the category of Major Shareholding Notification.
2025-12-19 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the upcoming 26th Annual General Meeting. It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal notice of the record date. Given the nature of the announcement as a regulatory disclosure regarding shareholder rights and meeting preparation, it fits best under the general regulatory filing category.
2025-12-16 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the acquisition of convertible bonds before maturity, including specifics such as bond type, issuance date, conversion price, maturity date, acquisition amount, and reasons for acquisition. It also references related disclosures and adjustments to conversion prices. The content focuses on capital structure changes related to convertible bonds and their early acquisition. This fits the category of Capital/Financing Update (CAP), as it provides updates on financing activities and capital structure changes. The document length is 3416 characters, which is sufficient for a detailed announcement rather than a brief notice or a report publication announcement.
2025-10-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.